Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
MRX Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Marex Group plc Ordinary SharesNASDAQ: MRX
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation outflow shrinks to $0
Q2 FY2026 stock-based compensation was $0, compared with $16.5M a year earlier. Over 3 fiscal years it compounded at +37.6% a year.
Context
- Stock-based compensation amounted to 1.2% of revenue in FY2025, up 0.2 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 43.5M USD
- Year-over-year change
- +47.0%
- 4-year CAGR
- +145.4%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 43.5M | +47.0% |
| FY2024 | 2024-12-31 | 29.6M | +45.8% |
| FY2023 | 2023-12-31 | 20.3M | +21.6% |
| FY2022 | 2022-12-31 | 16.7M | +1291.7% |
| FY2021 | 2021-12-31 | 1.2M | — |
Stock-Based Compensation vs competitors
How MRX compares with its peers on the latest reported figures
- MRX's FY2025 stock-based compensation of $43.5M is the 9th largest of the 10 companies compared; the peer median is $177M.
- Its year-over-year change of +47.0% is the 2nd highest of 10, against a peer median of +11.5%.
- Stock-based compensation amounts to 1.2% of revenue for MRX, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.46B | +9.1% | -5.5% | 2.9% | |
| LTM Sep 2026 | $1.6B | -13.3% | +0.9% | 1.2% | |
| LTM Jun 2026 | $444.62M | +174.4% | +6.6% | 6.7% | |
| LTM Jun 2026 | $246.67M | -32.6% | +9.5% | 7.3% | |
| LTM Sep 2026 | $177M | +12.0% | +15.9% | 1.9% | |
| LTM Aug 2026 | $116.18M | +40.0% | +26.2% | 0.9% | |
| LTM Jun 2026 | $81M | -17.9% | +15.8% | 3.7% | |
| LTM Jun 2026 | $56.1M | +25.8% | +40.1% | 0.0% | |
MRXMarex Group plc Ordinary Shares | FY2025 | $43.5M | +47.0% | +37.6% | 1.2% |
| LTM Jun 2026 | $33.4M | +11.5% | +1.2% | 3.8% | |
| Peer median (excluding MRX) | $177M | +11.5% | +9.5% | 2.9% | |
Competitors are the stored peer set for MRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 56.5M | 98.2M | 141.3M | 295.8M | 307.4M |
| Depreciation & Amortization | 10.3M | 13.8M | 21.9M | 28.8M | 36.1M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.2M | 16.7M | 20.3M | 29.6M | 43.5M |
| Change in Working Capital | 183.5M | (22M) | 609M | 1.04B | 371.2M |
| Accounts Receivables | (1.57B) | 3.14B | 777.6M | (2.76B) | (2.57B) |
| Inventory | (71.4M) | 44.3M | (127.6M) | 127.6M | (422M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 1.82B | (3.21B) | (41M) | 3.67B | 3.36B |
| Other Non-Cash Items | 219.3M | 118.9M | (57.5M) | (231.1M) | (90.7M) |
| Operating Cash Flow | 470.8M | 225.6M | 735M | 1.16B | 667.5M |
| Capital Expenditures | (7.3M) | (9.4M) | (12.1M) | (19.9M) | (13.1M) |
| Acquisitions (Net) | (12.5M) | (36.9M) | (90.3M) | (11M) | (241.6M) |
| Purchases of Investments | 0 | 0 | 0 | (5.1M) | (2.9M) |
| Sales of Investments | 0 | 0 | 6.4M | 700K | 0 |
| Other Investing Activities | 0 | 0 | (4.7M) | (8.2M) | 0 |
| Investing Cash Flow | (19.8M) | (46.3M) | (97.6M) | (35.3M) | (264.3M) |
| Debt Repayment | (7.2M) | 43.4M | (11.4M) | (8.6M) | (24.3M) |
| Common Stock Issued | 0 | 0 | 0 | 73.1M | 0 |
| Common Stock Repurchased | 0 | (7.9M) | (3.1M) | (19.8M) | (44.1M) |
| Dividends Paid | (20M) | (6.6M) | (58.3M) | (77.1M) | (55.5M) |
| Other Financing Activities | 0 | (2.4M) | 0 | 0 | 0 |
| Financing Cash Flow | (27.2M) | 26.5M | (72.8M) | (37.2M) | (123.9M) |
| Effect of Forex Changes | (3.3M) | (7.7M) | 8.8M | (17.9M) | 7.05B |
| Net Change in Cash | 420.5M | 198.1M | 573.4M | 1.07B | 7.33B |
| Free Cash Flow | 463.5M | 216.2M | 722.9M | 1.14B | 654.4M |
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.